Neuralink 2026: Scaling BCIs with Mass Production and Automated Surgery 2 January 2026·399 words·2 mins Neuralink Biotechnology Robotics Healthcare
FDA Approves NEREUS: First New Motion Sickness Drug in Decades 1 January 2026·502 words·3 mins FDA Approval Pharmaceuticals Motion Sickness Neuropharmacology
AI Unlocks New Frontiers in RNA Drug Design 31 December 2025·617 words·3 mins Biotechnology Artificial Intelligence Drug Development RNA Therapeutics
Targeting CSE Enzyme Opens New Paths for Alzheimer’s Treatment 31 December 2025·606 words·3 mins Neuroscience Alzheimer’s Disease Medical Research Brain Health
Why Alzheimer’s Trials Must Address Sex Differences 30 December 2025·463 words·3 mins Medical Research Alzheimer’s Clinical Trials Precision Medicine
J&J Acquires Halda Therapeutics for $3.05B 30 December 2025·369 words·2 mins Biopharma Oncology M&A Drug Discovery
Sanofi’s AlphaMedix Hits Key Efficacy Goals in Phase 2 Neuroendocrine Tumor Trial 9 October 2025·625 words·3 mins Sanofi AlphaMedix Radioligand Therapy Neuroendocrine Tumors Oncology Biotech Clinical Trials
Ozempic and Cancer: Exploring GLP-1 Drugs’ Potential in Oncology 22 September 2025·603 words·3 mins Ozempic GLP-1 Cancer Research Oncology Weight Loss Drugs Diabetes Drugs
How AI and Data are Shaping the Future of Inclusive Clinical Trials 22 September 2025·1108 words·6 mins AI in Healthcare Clinical Trials Diversity in Clinical Trials Patient Recruitment
Multiply Labs Biomanufacturing Robot Set to Slash Cell Therapy Costs 5 September 2025·464 words·3 mins Cell Therapy Gene Therapy Biomanufacturing Automation Robotics Multiply Labs CGT Healthcare Innovation
